Page 10 - National Stock Exchange

PSP Projects slips 4% after Q4 profit plunges 66%; check details here

PSP Projects stock fell as much as 4.27 per cent to hit an intraday low of Rs 656.20 per share

Bayer CropScience stock declines 6% on Friday post Q4; Check details here

Bayer CropScience's revenue slipped 19.5 per cent on a year-on-year (Y-o-Y) basis to Rs 792 crore as opposed to Rs 983 crore in the same quarter a year ago

JK Lakshmi Cement shares rally 7% on healthy Q4; up 15% in last one year

The surge in JK Lakshmi Cement share was fuelled by robust Q4FY24 results, which came in line with street estimates

PG Electroplast soars 11%, hits record high on solid Q4, 1:10 stock split

PGEL forecasts revenues of Rs 3,400 crore, a growth of 23.8 per cent over FY24 consolidated revenues, despite the transfer of the TV business to Goodworth Electronics

Paytm drops 3% after Q4 loss broadens; check trading strategy here

The decline followed the company's announcement of its Q4 results, which fell short of market expectations. Paytm's loss widened to Rs 549.6 crore in Q4FY24

Kaynes Tech zooms 14% on robust Q4; stock more-than-doubles in one year

Notably, the stock has zoomed almost 339 per cent from its listing price of Rs 578, and 121 per cent in the last one year

NSE, BSE special mkt session on Saturday, May 18: Check timing, price bands

NSE, BSE Special session: Here's why stock markets are open on Saturday, May 18

Stocks to keep on your radar on May 17: IIFL Securities, Prince Pipes, KIMS

Across Asia, trading sentiment dipped as retail sales data fell short of street expectations, with a modest 2.3 per cent increase in April compared to the previous year

Motilal Oswal Midcap Fund: High concentration, consistent performance

The fund aims for long-term capital appreciation by investing in quality midcap companies with sustainable competitive advantages and significant growth potential

Strides Pharma rises 3% after US FDA approves Hypocalcemia drug

The rise came after the company announced that the United States Food and Drug Administration (US FDA) has approved its Sevelamer carbonate tablets 800 mg

Sensex sinks 1100 pts intraday, Nifty breaks 22k on May 9: Key reasons here

The benchmark S&P BSE Sensex dropped by as much as 1,132 points to hit an intraday, while the Nifty 50 dropped to 21,932

NSE to run special trading session on May 18 with disaster recovery switch

The special live trading session will have intra-day switch over from primary site to disaster recovery site

Sebi rejects NSE's proposal to extend trading hours for equity derivatives

Capital markets regulator Sebi has rejected a proposal by the National Stock Exchange (NSE) to extend the trading hours in the equity derivatives segment citing a lack of feedback from the stock brokers community. "Currently, there is no plan to extend the timings as Sebi has returned our application as the stock brokers have not given the feedback that Sebi wanted. So, as of now, the extended time frame (plan) is shelved," NSE MD and CEO Ashishkumar Chauhan said in a post-earnings analysts call. This came after the NSE had urged Sebi to extend trading hours in the equity derivatives segment in a phased manner. This was aimed at potentially curtailing the overnight risk arising from global information flow. Sriram Krishnan, Chief Business Development Officer of NSE, had told PTI in September that the bourse was planning a session from 6 pm to 9 pm after a break from the closure of the regular session from 9.15 am to 3.30 pm. Based on the response, a gradual extension of the market .

Arvind shares jump over 6%, hits record high after Q4 results

Arvind's topline grew 8.7 per cent year-on-year (Y-o-Y) to Rs 2,074.5 crore in Q4FY24, compared to Rs 1,880.7 crore in the corresponding period of the previous fiscal year

NSE investors may face further delays for its initial public offering

According to industry players, one of the key requirements for approving NSE's IPO is for it to remain free from any tech-glitch for a year

Winsol Engineers IPO opens on May 6: Check subscription, GMP, price band

The company plans to utilise the net proceeds for working capital requirements and general corporate purposes

BSE, NSE spar over derivatives markets, lure investors with lower fees

The NSE plans to launch options contracts based on key sectoral indices, including the pharmaceutical and IT indices, if it gets the regulatory go-ahead, according to two exchange sources

Street Signs: Navigating market rapids, IPO Street set to sparkle, and more

The grey market premiums (GMPs) for the three initial public offerings (IPOs) that open this week range between 20 per cent and 55 per cent

NSE Q4 results: Net profit rises 20% to Rs 2,478 crore, revenue up 34%

NSE also disclosed that it had filed a revised settlement plea with Sebi on March 5 in the trading access point (TAP) matter. It said it is awaiting a revert from Sebi on its plea

ChrysCapital closes its $700 million continuation fund in India

The NSE has been planning an initial public offering but needs approval from the Securities and Exchange Board of India (SEBI)